PREVENT, its creators acknowledge, is an experiment. If it can retain accuracy in predicting heart disease risk without using ...

Around 6% of middle and high school students used vapes in 2024, down from 8% last year, and a record high of 20% in 2019, ...

FDA staffers have not returned to roughly 2,000 pharmaceutical manufacturing firms to conduct surveillance inspections since ...

Eli Lilly announced more positive results on its weekly insulin, called efsitora alfa, in type 2 diabetes patients. The ...

As Medicare telehealth flexibilities rapidly approach their expiration date, researchers from Cornell examined 2022 Medicare ...

Limiting our health defense to just some threats would be like allowing our military to protect us from only some types of ...

A CRISPR-augmented stem cell transplant has shown preliminary evidence that it can delay relapse in some cancer patients.

STAT's The Readout Loud covers an upcoming presentation from Summit Therapeutics, mixed data from Recursion, and amylin ...

Police in China have detained five current and former employees of AstraZeneca for questioning about potential illegal ...

Last June, Summit Therapeutics created a lot of buzz — and sent its stock surging — when it announced top-line results ...

Looking for successors to the blockbuster GLP-1 obesity drugs, companies like Novo Nordisk and Eli Lilly are testing amylin ...

Today's health news roundup includes the battle over race in kidney function equations and why some older adults don't fill ...